Impact of renal dysfunction on the prognostic value of the TIMI risk score in patients with non-ST elevation acute coronary syndrome

Jason Go, Ann Narmi, John Sype, Aryan N. Mooss, Daniel E. Hilleman

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

BACKGROUND: The thrombolysis-in-myocardial-infarction risk score (TRS) is a validated risk-assessment tool based on randomized clinical trials. Its applicability to an unselected group of patients seen in general clinical practice may be limited as renal dysfunction was an exclusion criteria in the original trials upon which the TRS was determined. MATERIALS AND METHODS: Consecutive patients with non-ST elevation acute coronary syndrome were stratified based on renal function. Normal renal function was defined as a creatinine clearance (CrCl) of more than 60 ml/min, moderate renal dysfunction was defined as a CrCl of at least 30 ml/min but 60 ml/min or less, and severe renal dysfunction was defined as a CrCl of less than 30 ml/min. A TRS was calculated using the original seven criteria (TRS-7) which did not consider renal function. A second TRS was calculated using the original seven criteria plus the addition of renal dysfunction if the CrCl was 60 ml/min or less (TRS-8≤60). A third TRS was calculated using the original seven criteria plus renal dysfunction if the CrCl was less than 30 ml/min (TRS-80.05). At a calculated TRS of 6 or 7, the TRS-8

Original languageEnglish
Pages (from-to)411-415
Number of pages5
JournalCoronary Artery Disease
Volume22
Issue number6
DOIs
StatePublished - Sep 2011

Fingerprint

Acute Coronary Syndrome
Kidney
Creatinine
General Practice
Randomized Controlled Trials
Myocardial Infarction

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Impact of renal dysfunction on the prognostic value of the TIMI risk score in patients with non-ST elevation acute coronary syndrome. / Go, Jason; Narmi, Ann; Sype, John; Mooss, Aryan N.; Hilleman, Daniel E.

In: Coronary Artery Disease, Vol. 22, No. 6, 09.2011, p. 411-415.

Research output: Contribution to journalArticle

@article{a6821a57c67a425db7ea36fb6428a359,
title = "Impact of renal dysfunction on the prognostic value of the TIMI risk score in patients with non-ST elevation acute coronary syndrome",
abstract = "BACKGROUND: The thrombolysis-in-myocardial-infarction risk score (TRS) is a validated risk-assessment tool based on randomized clinical trials. Its applicability to an unselected group of patients seen in general clinical practice may be limited as renal dysfunction was an exclusion criteria in the original trials upon which the TRS was determined. MATERIALS AND METHODS: Consecutive patients with non-ST elevation acute coronary syndrome were stratified based on renal function. Normal renal function was defined as a creatinine clearance (CrCl) of more than 60 ml/min, moderate renal dysfunction was defined as a CrCl of at least 30 ml/min but 60 ml/min or less, and severe renal dysfunction was defined as a CrCl of less than 30 ml/min. A TRS was calculated using the original seven criteria (TRS-7) which did not consider renal function. A second TRS was calculated using the original seven criteria plus the addition of renal dysfunction if the CrCl was 60 ml/min or less (TRS-8≤60). A third TRS was calculated using the original seven criteria plus renal dysfunction if the CrCl was less than 30 ml/min (TRS-80.05). At a calculated TRS of 6 or 7, the TRS-8",
author = "Jason Go and Ann Narmi and John Sype and Mooss, {Aryan N.} and Hilleman, {Daniel E.}",
year = "2011",
month = "9",
doi = "10.1097/MCA.0b013e3283487de2",
language = "English",
volume = "22",
pages = "411--415",
journal = "Coronary Artery Disease",
issn = "0954-6928",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Impact of renal dysfunction on the prognostic value of the TIMI risk score in patients with non-ST elevation acute coronary syndrome

AU - Go, Jason

AU - Narmi, Ann

AU - Sype, John

AU - Mooss, Aryan N.

AU - Hilleman, Daniel E.

PY - 2011/9

Y1 - 2011/9

N2 - BACKGROUND: The thrombolysis-in-myocardial-infarction risk score (TRS) is a validated risk-assessment tool based on randomized clinical trials. Its applicability to an unselected group of patients seen in general clinical practice may be limited as renal dysfunction was an exclusion criteria in the original trials upon which the TRS was determined. MATERIALS AND METHODS: Consecutive patients with non-ST elevation acute coronary syndrome were stratified based on renal function. Normal renal function was defined as a creatinine clearance (CrCl) of more than 60 ml/min, moderate renal dysfunction was defined as a CrCl of at least 30 ml/min but 60 ml/min or less, and severe renal dysfunction was defined as a CrCl of less than 30 ml/min. A TRS was calculated using the original seven criteria (TRS-7) which did not consider renal function. A second TRS was calculated using the original seven criteria plus the addition of renal dysfunction if the CrCl was 60 ml/min or less (TRS-8≤60). A third TRS was calculated using the original seven criteria plus renal dysfunction if the CrCl was less than 30 ml/min (TRS-80.05). At a calculated TRS of 6 or 7, the TRS-8

AB - BACKGROUND: The thrombolysis-in-myocardial-infarction risk score (TRS) is a validated risk-assessment tool based on randomized clinical trials. Its applicability to an unselected group of patients seen in general clinical practice may be limited as renal dysfunction was an exclusion criteria in the original trials upon which the TRS was determined. MATERIALS AND METHODS: Consecutive patients with non-ST elevation acute coronary syndrome were stratified based on renal function. Normal renal function was defined as a creatinine clearance (CrCl) of more than 60 ml/min, moderate renal dysfunction was defined as a CrCl of at least 30 ml/min but 60 ml/min or less, and severe renal dysfunction was defined as a CrCl of less than 30 ml/min. A TRS was calculated using the original seven criteria (TRS-7) which did not consider renal function. A second TRS was calculated using the original seven criteria plus the addition of renal dysfunction if the CrCl was 60 ml/min or less (TRS-8≤60). A third TRS was calculated using the original seven criteria plus renal dysfunction if the CrCl was less than 30 ml/min (TRS-80.05). At a calculated TRS of 6 or 7, the TRS-8

UR - http://www.scopus.com/inward/record.url?scp=80051796898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051796898&partnerID=8YFLogxK

U2 - 10.1097/MCA.0b013e3283487de2

DO - 10.1097/MCA.0b013e3283487de2

M3 - Article

C2 - 21691204

AN - SCOPUS:80051796898

VL - 22

SP - 411

EP - 415

JO - Coronary Artery Disease

JF - Coronary Artery Disease

SN - 0954-6928

IS - 6

ER -